Excitotoxicity: Bridge to various triggers in neurodegenerative disorders

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 6-18

  Mehta, Ankita ^a   Prabhakar, Mayank ^a   Kumar, Puneet ^a   Deshmukh, Rahul ^a   Sharma, P L ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Calcium overload; Excitotoxicity; Glutamate; Mitochondrial dysfunction; Neurodegenerative diseases; Oxidative stress; Therapeutics

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE TRIPHOSPHATE; CALCIUM; CHLORINE; COGANE; COLECALCIFEROL; CURCUMIN; FARNOQUINONE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSANOID; LIPOXYGENASE; METFORMIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; NITRIC OXIDE; NOOTROPIC AGENT; PERAMPANEL; PHOSPHODIESTERASE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; TENECTEPLASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINIFERIN;

ALCOHOL WITHDRAWAL; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN NERVE CELL; CELL DEATH; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPILEPSY; EXCITOTOXICITY; GABAERGIC SYSTEM; GLUTAMATERGIC SYSTEM; HEARING IMPAIRMENT; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; MULTIPLE SCLEROSIS; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; GLUTAMIC ACID; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROTRANSMITTER AGENTS; RECEPTORS, GLUTAMATE;

EID: 84871919598     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.10.032     Document Type: Review

References (154)

1. T. Abel, and R.S. Zukin Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders Curr. Opin. Pharmacol. 8 2008 57 64
2. V. Adam-Vizi Neuroprotective effect of sodium channel blockers in ischemia: the pathomechanism of early ischemic dysfunction Orv. Hetil. 141 2000 1279 1286
3. A. Akaike, S. Kaneko, Y. Tamura, N. Nakata, H. Shiomi, F. Ushikubi, and S. Narumiya Prostaglandin E2 protects cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity Brain Res. 663 2 1994 237 243
4. B.C. Albensi, and M.P. Mattson Evidence for the involvement TNF and NF-κB in hippocampal synaptic plasticity Synapse 35 2000 151 159 (Pubitemid 30036192)
5. Alexandra, M. Kaufman, J.Milnerwood. Austen, D.Sepers. Marja, Coquinco. Ainsley, She. Kevin, Wang. Liang, Lee. Hwan, Marie, Craig. Ann, Cynader. Max, and A.Raymond. Lynn Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons J. Neurosci. 32 12 2012 3992 4003
6. C.Flint. Alexander Taking Cholesterol Drugs in Hospital May Improve Stroke Outcomes 2012 Kaiser Permanente California, US
7. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem. J. 357 2001 593 615 (Pubitemid 32735142)
8. C. Asomugha, D. Linn, and C. Linn ACh receptors link two signaling pathways to neuroprotection against glutamate-induced excitotoxicity in isolated RGCs J. Neurochem. 112 2010 214 226
9. A. Atlante, D. Valenti, S. Gagliardi, and S. Passarella Sensitive method to assay the xanthine oxidase activity in primary cultures of cerebellar granule cells Brain Res. Protoc. 6 1-2 2000 1 5
10. K. Aquilano, S. Baldelli, G. Rotilio, and M.R. Ciriolo Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols Neurochem. Res. 33 2008 2416 2426
11. 2+ exchanger in excitotoxicity Cell 120 2005 275 285 (Pubitemid 40174769)
12. J. Barrett, Y. Song, W.D. Van, Horn, E.J. Hustedt, J.M. Schafer, A. Hadziselimovic, A.J. Beel, and C.R. Sanders The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol Science 336 6085 2012 1168
13. S. Balogh, S.E. Hendricks, and J. Kang Treatment of fluoxetine-induced anorgasmia with amantadine J. Clin. Psychia 53 6 1992 212 213
14. Z. Babot, R. Cristó fol, and C. Suñol Excitotoxic death induced by released glutamate in depolarized primary cultures of mouse cerebellar granule cells is dependent on GABAA receptors and niflumic acid-sensitive chloride channels Eur. J. Neurosci. 21 2005 103 112 (Pubitemid 40193879)
15. 2+exchanger in excitotoxicity Cell 120 2005 275 285 (Pubitemid 40174769)
16. Y. Ben-Ari Excitatory actions of GABA during development: the nature of the nurture Nat. Rev. Neurosci. 3 2002 728 739 (Pubitemid 135706678)
17. E. Berdichevsky, N. Riveros, S. Sanchez-Armass, and F. Orrego Kainate, N-methylaspartate and other excitatory amino acids increase calcium influx into rat brain cortex cells in vitro Neurosci. Lett. 36 1983 75 80 (Pubitemid 13083403)
18. K. Bian, and F. Murad Nitric oxide (NO) biogeneration, regulation and relevance to human diseases Frontiers. Biosci. 8 2003 264 278
19. G. Bicker Pharmacological approaches to nitric oxide signalling during neural development of locusts and other model insects Arch. Insect Biochem. Physiol. 64 2007 43 58 (Pubitemid 46160153)
20. Z.A. Bortolotto, Z.I. Bashir, C.H. Davies, and G.L. Collingridge A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation Nature 368 1994 740 743 (Pubitemid 24153413)
21. M. Brandon, P. Baldi, and D.C. Wallace Mitochondrial mitations in cancer Oncogene 25 34 2006 4647 4662
22. D.L. Brody, and D.M. Holtzman Active and passive immunotherapy for neurodegeneration disorders Annu. Rev. Neurosci. 31 2008 175 193
23. Londono Carolina, Osorio Cristina, Gama Vivian, and Alzat. Oscar Mortalin, apoptosis, and neurodegeneration Biomolecules 2 1 2012 143 164
24. C.J. Chen, S.L. Liao, and J.S. Kuo Gliotoxic action of glutamate on cultured astrocytes J. Neurochem. 75 2000 1557 1565
25. Q.-Y. Chen, S. Alarcon, and A. Tharp Perceptual variation in umami taste and polymorphisms in TAS1R taste receptor genes Am. J. Clin. Nutr. 90 suppl 2009 770S 779S
26. H.S. Chen, and S.A. Lipton The chemical biology of clinically tolerated NMDA receptor antagonists J. Neurochem. 97 2006 1611 1626 (Pubitemid 43873656)
27. D.W. Choi, J.-Y. Koh, and S. Peters Pharmacology glutamaten eurotoxicity in cortical cell culture: attenuationb NMDA antagonists J. Neurosci. 8 1988 185 196 (Pubitemid 18038308)
28. N.J. Chinoy, and S.D. Shah Biochemical effects of sodium fluoride and arsenic trioxide toxicity and their reversal in the brain of mice Fluoride 37 2 2004 80 87 (Pubitemid 39280423)
29. M. Clare, and A. Gladding., Lynn Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function Mol. Cell. Neurosci. 48 4 2011 308 320
30. A.Gautier. Clement, Giaime Emilie, Caballero Erica, Núñez Lucía, Song Zhiyin, Chan David, Villalobos Carlos, and Shen Jie Regulation of mitochondrial permeability transition pore by PINK1 Mol. Neurodegener. 7 2012 1 22
31. K.S. Collison, Z. Maqbool, and S.M. Saleh Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease J. Lip. Res. 50 8 2009 1521 1537
32. P.J. Conn, C.W. Lindsley, C.R. Hopkins, C.M. Niswender, R.D. Gogliotti, and J.M. Salovich Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat. Rev. Drug Discov. 8 2009 41 54
33. C.M. Cowan, M.M. Fan, J. Fan, J. Shehadeh, L.Y. Zhang, and R.K. Graham Polyglutamine-modulated striatal calpain activity in YAC transgenic Huntington disease mouse model: impact on NMDA receptor function and toxicity J. Neurosci. 28 2008 12725 12735
34. Crossman Functional anatomy of movement disorders J. Anat. 196 4 2000 519 525 (Pubitemid 30458774)
35. Dan Structure and mechanism of a glutamate-GABA antiporter Nature 483 2012 632 636
36. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
37. Dutta Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis Prog. Neurobiol. 93 1 2011 1 12
38. Emmitte Recent advances in the design and development of novel negative allosteric modulators of mGlu(5). ACS Chem. Neurosci. 2 8 2011 411 432
39. A. Eisenberg-Lerner, S. Bialik, H.U. Simon, and A. Kimchi Life and death partners: apoptosis, autophagy and the cross-talk between them Cell Death Differ. 16 2009 966 975
40. A.A. Farooqui, W.Y. Ong, and L.A. Horrocks Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration Curr. Drug. Targets. Cardiovasc. Haematol. Disord. 4 1 2004 85 96 (Pubitemid 38404717)
41. H. Fiumelli, and M.A. Woodin Role of activity-dependent regulation of neuronal chloride homeostasis in development Curr. Opin. Neurobiol. 17 2007 81 86 (Pubitemid 46227981)
42. S. Fuke, and S. Konosu Taste-active components in some foods: review of Japanese literature Physiol. Behav. 49 1991 863 868
43. T. Farooqui, and A.A. Farooqui Aging: an important factor for the pathogenesis of neurodegenerative diseases Mech. Ageing Dev. 130 2009 203 215
44. Gagliardi Neuroprotection, excitotoxicity and NMDA antagonists Arq. Neuro-Psiquiatr. 58 2000 583 588
45. Gamba Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters Physiol. Rev. 85 2005 423 493 (Pubitemid 40404634)
46. X. Gao, A. Cassidy, M.A. Schwarzschild, E.B. Rimm, and A. Ascherio Habitual intake of dietary flavonoids and risk of Parkinson's disease Neurology 2012 10.1212/WNL.0b013e31824f7fc4
47. Goto The identification and functional implications of human-specific fixed amino acid substitutions in the glutamate receptor family BMC Evol. Bio. 9 2009 200 224
48. M. Gottlieb, Y. Wang, and V.I. Teichberg Blood-mediated scavenging of cerebrospinal fluid glutamate J. Neurochem. 87 2003 119 126 (Pubitemid 37210646)
49. P. Ghafourifar, U. Bringold, S.D. Klein, and C. Richter Mitochondrial nitric oxide synthase, oxidative stress and apoptosis Biol. Signals Recept. 10 2001 57 65 (Pubitemid 32171158)
50. C.K. Glass, K. Saijo, B. Winner, M.C. Marchetto, and F.H. Gage Mechanisms underlying inflammation in neurodegeneration Cell 140 2010 918 934
51. G.W. Glazner, S.L. Chan, C. Lu, and M.P. Mattson Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis J. Neurosci. 20 2000 3641 3649 (Pubitemid 30266227)
52. Griffin Inflammation and neurodegenerative diseases Am. J. Clin. Nutr. 83 2 2006 470S 474S (Pubitemid 44713221)
53. Grundman Vitamin E and Alzheimer disease: the basis for additional clinical trials Am. J. Clin. Nutr. 71 2000 630S 636S (Pubitemid 30061248)
54. G.E. Hardingham, and H. Bading Synaptic versus extrasynaptic NMDA receptor signaling: implications for neurodegenerative disorders Nat. Rev. Neurosci. 11 10 2010 682 696
55. Hari Putative role of neuronal 5-lipoxygenase in an aging brain Faseb. J. 14 2000 1464 1469
56. Handley Pharmaceutical, cellular and genetic therapies for Huntington's disease Clin. Sci. 110 2006 73 88 (Pubitemid 43059046)
57. Edward Hallowell, M. John, and J. Ratey. Delivered from Distraction: Getting the Most out of Life with Attention Deficit Disorder 2005 Ballantine Books 253-255
58. M. Hollmann, and S. Heinemann Cloned glutamate receptors Annu. Rev. Neurosci. 17 1994 31 108 (Pubitemid 24117025)
59. Hawkins The blood-brain barrier and glutamate Am. J. Clin. Nutr. 90 suppl 2009 867S 874S
60. M.T. Heneka, J.J. Rodriguez, and A. Verkhratsky Neuroglia in neurodegeneration Brain Res. Rev. 63 2010 189 211
61. T.K. Hensch, and M.P. Stryker Columnar architecture sculpted by GABA circuits in developing cat visual cortex Science 303 2004 1678 1681 (Pubitemid 38338327)
62. S.J. Hewett, T.F. Uliasz, A.S. Vidwans, and J.A. Hewett Cyclooxygenase-2 contributes to N-methyl-d-aspartate-mediated neuronal cell death in primary cortical cell culture J. Pharmacol. Exp. Ther. 293 2 2000 417 425 (Pubitemid 30244090)
63. M. Hynd, H. Scott, and P. Dodd Differential expression of N-methyl-d-aspartate receptor NR2 isoforms in Alzheimer's disease J. Neurochem. 90 2004 913 919 (Pubitemid 39099973)
64. C. Ikonomidou, and L. Turski Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet. Neurol. 1 6 2002 383 386 (Pubitemid 37159164)
65. C. Iadecola, and M. Alexander Cerebral ischemia and inflammation Curr. Opin. Neurol. 14 1 2001 89 94 (Pubitemid 32116263)
66. Jankovic Parkinson's disease: clinical features and diagnosis J. Neurol. Neurosurg. Psychiatr. 79 4 2008 368 376 (Pubitemid 351441488)
67. Jeffrey, C. Watkins, and E.Jane. David The glutamate story Br. J. Pharmacol. 147 S1 2006 S100 108
68. Jinrong, Fu., Jing Jin., Robert, H. Cichewicz., Serena, A. Hageman., Trevor, K. Ellis., Lan, Xiang., Qi Peng., Mali, Jiang., Nicolas, Arbez., Katelyn, Hotaling., Christopher, A. Ross., Wenzhen, Duan., 2012. Trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease. J. Biol. Chem. 287, 24460-24472.
69. M.P. Johnson, E.S. Nisenbaum, T.H. Large, R. Emkey, M. Baez, and A.E. Kingston Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists Biochem. Soc. Trans. 32 Pt 5 2004 881 887 (Pubitemid 39524404)
70. Wu. Jun, Shih Hsin-Pei, Vigont Vladimir, Hrdlicka Lori, Diggins Len, Singh Carol, Mahoney Matt, Chesworth Richard, Shapiro Gideon, and Zimina Olga Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment Chem. Bio. 18 6 2011 777 793
71. L.V. Kalia, S.K. Kalia, and M.W. Salter NMDA receptors in clinical neurology: excitatory times ahead Lancet. Neurol. 7 2008 742 755 (Pubitemid 351957932)
72. Krebs The gourmet ape: evolution and human food preferences Am. J. Clin. Nutr. 90 Suppl 2009 707S 711S
73. G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial membrane permeabilization in cell death Physiol. Rev. 87 1 2007 99 163 (Pubitemid 46209992)
74. P. Kumar, H. Kalonia, and A. Kumar Role of LOX/COX pathways in 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: protective effect of licofelone Br. J. Pharmacol. 164 2b 2011 644 654
75. P. Kumar, H. Kalonia, and A. Kumar Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity Eur. J. Parmacol. 674 2-3 2012 265 274
76. P. Kumar, H. Kalonia, and A. Kumar Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavoural, oxidative, neurochemical, and mitochondrial alterations in rat brain Drug Chem. Toxicol. 33 4 2010 377 392
77. M. Kaul, G.A. Garden, and S.A. Lipton Pathways to neuronal injury and apoptosis in HIV-associated dementia Nature 410 2001 988 994 (Pubitemid 32335850)
78. Krauss, G.L., Serratosa, J.M., Villanueva, V., Endziniene, M., Hong, Z., French, J., Yang, H.D., Squillacote, D., Edwards, H.B., Zhu, J., Laurenza, A., 2012. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology, 10.1212/WNL.0b013e318254473a
79. F. Kurzel, C. Hagel, S. Zapf, H. Meissner, M. Westphal, and A. Giese Cyclooxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma cells Acta Neurochir. (Wien) 144 1 2002 71 87 (Pubitemid 34117851)
80. D. Lau, and H. Bading Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition J. Neurosci. 29 2009 4420 4429
81. Liang Negative regulation of autophagy Cell Death Differ. 17 2010 1807 1815
82. Lipton NMDA receptor activity regulates transcription of antioxidant pathways Nat. Neurosci. 11 2008 381 382a
83. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 7113 2006 787 795 (Pubitemid 44622683)
84. Molochnikov. Leonid, M.Rabey Jose, Dobronevsky Evgenya, Bonucelli Ubaldo, Ceravolo Roberto, Frosini Daniela, Grünblatt Edna, Riederer Peter, Jacob Christian, Aharon-Peretz Judith, Bashenko Yulia, B.H.Youdim Moussa, and A.Mandel Silvia A molecular signature in blood identifies early Parkinson's disease Mol. Neurodegeneration 7 2012 1 26
85. P. Leighton, Robert W. Marka, John L. Prosta, Michelle M. Ulmera, David L. Smitha, James M. Danielsa, W. Strottmanna, Browna Douglas, and Hacein-Beya Lotfi Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging Am. J. Neuroradiobio. 22 2001 1813 1824
86. F. Leveille Suppression of the intrinsic apoptosis pathway by synaptic activity J. Neurosci. 30 2010 2623 2635
87. C.H. Large, S. Bison, I. Sartori, K.D. Read, A. Gozzi, D. Quarta, and M.E. Antolini The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for Schizophrenia J. Pharmacol. Exp. Ther. 338 1 2011 100 113
88. H.G. Lee, X. Zhu, G. Casadesus, M. Pallàs, A. Camins, and M.J. O'Neill The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival Brain. Res. 1249 2009 244 250
89. L. Mark, Meei-Shyuan Wahlqvist., Chih-Cheng Lee, Shao-Yuan Hsu, Jiunn-Tay Chuang, and Hsin-Ni Tsai Lee Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Rel Disorders 2012
90. Mark.G. Moloney Excitatory amino acids Nat. Prod. Rep. 15 2 1998 205 219
91. Michael, Benatar, Zane, Zeier, Claes, Wahlestedt, 2012. Therapy development for C9orf72 related disease: an antisense oligonucleotide-based approach. 〈http://www.alsa.org/news/the-als-association-announces. html〉.
92. Magistretti Role of glutamate in neuron-glia metabolic coupling Am. J. Clin. Nutr. 90 suppl 2009 875S 880S
93. M. Mancuso, D. Orsucci, A. LoGerfo, V. Calsolaro, and G. Siciliano Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA Adv. Exp. Med. Bio. 685 2010 34 44
94. Allen. Mariet, Zou. Fanggeng, Seng Chai High, S.Younkin Curtis, Miles Richard, A.Nair Asha, E.Crook Julia, Pankratz Shane, M.Carrasquillo Minerva, and N.Rowley Christopher Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications Mol. Neurodegeneration 7 2012 1 13
95. A.B. Macdermott, M.L. Mayer, G.L. Westbrook, S.J. Smith, and J.L. Barker NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones Nature (London) 321 1986 519 522 (Pubitemid 16052255)
96. R.E. Mrak, and W.S.T. Griffin Glia and their cytokines in progression of neurodegeneration Neurobio. Aging 26 3 2005 349 354 (Pubitemid 40082718)
97. A.B. Maccarrone, M.L. Mayer, G.L. Westbrook, S.J. Smith, and J.L. Barker Lipoxygenases and their involvement in programmed cell death Cell Death Differ. 8 8 2001 776 784
98. J.P. Miller, J. Holcomb, I. Al-Ramahi, M. de Haro, J. Gafni, and N. Zhang Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease Neuron 67 2010 199 212
99. I. Munoz-Sanjuan, and G.P. Bates The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease J. Clin Invest. 121 2011 476 483
100. G. Nelson, J. Chandrashekar, M.A. Hoon, L. Feng, G. Zhao, N.J. Ryba, and C.S. Zuker An amino-acid taste receptor Nature 416 2002 199 202 (Pubitemid 34246480)
101. M.D. Norenberg, and K.V.R. Rao The mitochondrial permeability transition in neurologic disease Neurochem. Int. 50 7-8 2007 983 997 (Pubitemid 46962816)
102. Hu. Neng-Wei, Ondrejcak. Tomas, and J.Rowan Michael Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances Pharmacol. Biochem. Behav. 100 4 2012 885-862
103. J Maragakis. Nicholas, and D.Rothstein Jeffrey Mechanisms of disease: astrocytes in neurodegenerative disease Nat. Clin. Prac. Neurol. 2 2006 679 689
104. Nicholls Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures Curr. Mol. Med. 4 2004 149 177 (Pubitemid 38425912)
105. Nagata Apoptotic DNA fragmentation Exp. Cell. Res. 256 2000 12 18 (Pubitemid 30211161)
106. Othmer Encyclopedia of Chemical Technology. New York 1978 Wiley pp-1-2
107. Y. Okubo, H. Sekiya, S. Namiki, H. Sakamoto, S. Iinuma, M. Yamasaki, M. Watanabe, K. Hirose, and M. Iino Imaging extrasynaptic glutamate dynamics in the brain Proc. Nat. Acad. Sci. 107 2010 6526 6531
108. S. Okamoto Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant Huntingtin Nat. Med. 15 2009 1407 1413
109. A. Piau, F. Nourhashémi, C. Hein, C. Caillaud, and B. Vellas Progress in the development of new drugs in Alzheimer's disease J. Nutr. Health. Aging 15 1 2011 45 57
110. J.A. Payne, C. Rivera, J. Voipio, and K. Kaila Cation-chloride co-transporters in neuronal communication, development and trauma Trends Neurosci. 26 2003 199 206 (Pubitemid 36412002)
111. S. Papadia Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses Nat. Neurosci. 11 2008 476 487 (Pubitemid 351441886)
112. D. Pitt, P. Werner, and C.S. Raine Glutamate excitotoxicity in a model of multiple sclerosis Nat. Med. 6 2000 67 70 (Pubitemid 30048528)
113. J.W. Phillis, L.A. Horrocks, and A.A. Farooqui Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders Brain Res. Rev. 52 2 2006 201 243 (Pubitemid 44291802)
114. B.X. Ren, X.P. Gu, Y.G. Zheng, C.L. Liu, D. Wang, Y.E. Sun, and Z.L. Ma Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model Anesthesiology 116 1 2012 122 132
115. Rolls Functional neuroimaging of umami taste: what makes umami pleasant? Am. J. Clin. Nutr. 90 Suppl 2009 804S 813S
116. Sapolsky Robert Biology and Human Behavior: The Neurological Origins of Individuality 2nd ed. 2005 The Teaching Company pp.19, 20 of Guide Book
117. D.J. Rossi, T. Oshima, and D. Attwell Glutamate release in severe brain ischaemia is mainly by reversed uptake Nature 403 2001 316 321 (Pubitemid 30062388)
118. Renata, Siciliani, Scalco, Matias, Costa, Vieira., Edson, Vieira, Da Cunha, Filho., 2012. Amyotrophic lateral sclerosis and riluzole use during pregnancy: a case report. doi:10.3109/17482968.2012.673171.
119. P.S. Sastry, and K.S. Rao Apoptosis and the nervous system J. Neurochem. 74 2000 1 20 (Pubitemid 30012750)
120. Serena., 2012. New Drug Bests Standard Treatment for Certain Strokes. 〈http://consumer.healthday.com/Article.asp?AID=662955〉.
121. R.I. Stanika Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity Proc. Nat. Acad. Sci. 106 2009 9854 9859
122. J.R. Steinert, T. Chernova, and I.D. Forsythe Nitric oxide signaling in brain function, dysfunction, and dementia Neuroscientist 16 2010 435 452
123. D.J. Sheffler, K.J. Gregory, J.M. Rook, and P.J. Conn Allosteric modulation of metabotropic glutamate recptors Adv. Pharmacol. 62 2011 37 77
124. C. Shepherd, H. McCann, and G.M. Halliday Variations in the neuropathology of familial Alzheimer's disease Acta Neuropathol. 118 1 2009 37 52
125. Y. Suzuki, E. Jodo, S. Takeuchi, S. Niwa, and Y. Kayama Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats Neuroscience 114 3 2002 769 779 (Pubitemid 35247662)
126. F.X. Soriano Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability J. Neurosci. 26 2006 4509 4518 (Pubitemid 44315350)
127. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J. Pharm. Exp. Ther. 299 2001 12 20 (Pubitemid 32905113)
128. 4 administration after cerebral hypoxia - ischemia in newborn rats is related to the severity of brain damage Reprod. Sci. 14 2007 667 677 (Pubitemid 351903569)
129. Steinhäuser Quantification of the abrasive wear of a gold wedding ring.2008 Gold Bull 41 2005 41 57
130. I.G. Stavrovskaya, and B.S. Kristal The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death? Free Radical Biol. Med. 38 6 2005 687 697 (Pubitemid 40249739)
131. M. Swamy, K.N.S. Sirajudeen, and G. Chandran Nitric oxide (NO), citrullineNO cycle enzymes, glutamine synthetase, and oxidative status in kainic acid-mediated excitotoxicity in rat brain Drug Chem. Toxicol. 32 4 2009 326 331
132. N. Suzuki, N. Motohashi, A. Uezumi, S. Fukada, and T. Yoshimura NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS J. Clin. Invest. 117 2007 2468 2476 (Pubitemid 47494348)
133. Sarah, J. Tracy Alcoholism in America: from reconstruction to prohibition 2005 Johns Hopkins University Press Baltimore 31-52
134. K.Y. Tseng, A. Caballero, A. Dec, D.K. Cass, and N. Simak Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental Parkinsonism PLoS One 6 2011 e27187
135. C. Turkyilmaz, Z. Turkyilmaz, Y. Atalay, F. Soylemezoglu, and B. Celasun Magnesium pretreatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia Brain Res. 955 2002 133 137 (Pubitemid 35284843)
136. Cali'. Tito, Ottolini Denis, and Brini Marisa Mitochondria, calcium and endoplasmic reticulum stress in Parkinson's disease 2011 Department of Biological Chemistry, University of Padova Italy
137. V. Uribe, B.K. Wong, R.K. Graham, C.L. Cusack, N.H. Skotte, M.A. Pouladi, Y. Xie, K. Feinberg, Y. Ou, and Y. Ouyang Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice Hum. Mol. Genet. 1 9 2012 1954 1967
138. M. Vos, G. Esposito, J.N. Edirisinghe, S. Vilain, D.M. Haddad, J.R. Slabbaert, S. Van, Meensel, O. Schaap, and B. Strooper Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency Science 2012 10.1126/science.1218632
139. H.B. Vickery, and C.L.A. Schmidt The history of the discovery of the amino acids Chem. Rev. 9 1931 169 318
140. P. Vincent, and C. Mulle Kainate receptors in epilepsy and excitotoxicity Neuroscience 158 2009 309 323
141. W. Vandamme, K. Braet, L. Cabooter, and L. Leybaert Tumor necrosis factor alpha inhibits purinergic calcium signaling in blood-brain barrier endothelial cells J. Neurochem. 88 2 2003 411 421
142. T. Wada, M. Naito, H. Kenmochi, H. Tsuneki, and T. Sasaoka Chronic nicotine exposure enhances insulin-induced mitogenic signaling via up-regulation of alpha7 nicotinic receptors in isolated rat aortic smooth muscle cells Endocrinology 148 2007 790 799 (Pubitemid 46150780)
143. Walker Huntington's disease Lancet 369 9557 2007 218 228 (Pubitemid 46107685)
144. Jeffrey Watkins, C. Jane, and E. David The glutamate story Br. J. Pharmacol. 147 Suppl. 1 2006 S100 S108
145. B.P. Watkins, S.L. Petersen, and P.G. Ryan Interactions between seabirds and deep water hake trawl gear: an assessment of impacts in South African waters Anim. Conserv. 11 2008 247 254
146. A.R. West, and K.Y. Tseng Nitric oxide-soluble guanylyl cyclase-cyclic GMP signaling in the striatum: new targets for the treatment of Parkinson's disease? Front. Syst. Neurosci. 5 2011 1 55
147. Wood.,2003. Role of microglia in chronic neurodegenerative diseases. In: Neuroinflammation: Mechanisms and Management. Totowa, NJ: Humana Press. pp. 3-27.
148. Y. Wang, R. Han, Z.Q. Liang, J.C. Wu, X.D. Zhang, and Z.L. Gu An autophagic mechanism is involved in apoptotic death of rat striatal neurons induced by the non-N-methyl-d-aspartate receptor agonist kainic acid Autophagy 4 2008 214 226 (Pubitemid 351231185)
149. J.D. Woolley, B.K. Khan, N.K. Murthy, B.L. Miller, and K.P. Rankin The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease J. Clin. Psychiatry 72 2 2011 126 133
150. Dong. Xiao-xia, Wang. Yan, and Qin Zheng-hong Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases Acta Pharmacol. Sin. 30 4 2009 379 387
151. S. Yamamoto, M. Tomoe, K. Toyama, M. Kawai, and H. Uneyama Can dietary supplementation of monosodium glutamate improve the health of the elderly? Am. J. Clin. Nutr. 90 Suppl 2009 844S 849S
152. T.A. Yacoubian, S.R. Slone, A.J. Harrington, S. Hamamichi, J.M. Schieltz, and K.A. Caldwell Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease Cell Death Dis. 1 2010 e2
153. S.Y. Yu, D.C. Wu, L. Liu, Y. Ge, and Y.T. Wang Role of AMPA receptor trafficking in NMDA receptor-dependent synaptic plasticity in the rat lateral amygdala J. Neurochem. 106 2008 889 899
154. A. Zlotnik, B. Gurevich, and S. Tkachov Brain neuroprotection by scavenging blood glutamate Exp. Neurology 203 2007 213 220 (Pubitemid 44821179)